Search
for
Sort by
Research 841–870 of 1000+
- Treatment options for polycystic ovary syndrome
- Current Guidelines for Diagnosing PCOS
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Androgen sensitivity gateway to COVID‐19 disease severity
- Acne
- Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
- Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes
- Polycystic Ovary Syndrome: An Updated Overview Foregrounding Impacts of Ethnicities and Geographic Variations
- Criteria for Diagnosis of Polycystic Ovary Syndrome during Adolescence: Literature Review
- Reconsidering the Polycystic Ovary Syndrome (PCOS)
- Prevalence and accurate diagnosis of polycystic ovary syndrome in adolescents across world regions: a systematic review and meta-analysis
- Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
- Polycystic ovary syndrome and its management: In view of oxidative stress
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- Androgenic Hormone Profile of Adult Women with Acne
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence
- Prevalence of metabolic syndrome in the family members of women with polycystic ovary syndrome from North India
- Diagnosis and Management of Polycystic Ovary Syndrome in Adolescent Girls
- Current aspects of polycystic ovary syndrome: A literature review
- Clinical characteristics in Taiwanese women with polycystic ovary syndrome
- Approach to androgen excess in women: Clinical and biochemical insights
- Care for Adolescents With Polycystic Ovary Syndrome: Development and Prescribing Patterns of a Multidisciplinary Clinic
- Polycystic Ovarian Syndrome: Is It Time to Rename PCOS to HA-PODS?
- Activity of 17β-(N-Alkyl/arylformamido) and 17β-[(N-Alkyl/aryl) alkyl/arylamido]-4-methyl-4-aza-5α-androstan-3-ones as 5α-Reductase Inhibitors in the Hamster Flank Organ and Ear11The research has been supported by Endorecherche that is seeking patent protection for the new compounds. F. Labrie is President of Endorecherche.
- The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study
- Metabolic Syndrome, Hepatic Steatosis and Testosterone: A Matter of Sex
- Triglycerides, independent of Ferriman Gallwey Score, is a main determinant of free testosterone index in PCOS
- Polycystic Ovary Syndrome and the Potential for Nanomaterial-Based Drug Delivery in Therapy of This Disease
- No. 350-Hirsutism: Evaluation and Treatment